Therapeutic Intervention at Cellular Quality Control Systems in Alzheimer's and Parkinson's Diseases

E-ISSN： 1873-4286|17|31|3446-3459

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.31, 2011-10, pp. : 3446-3459

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Strategies for Alzheimer's and Parkinson's Diseases by Means of Drug Delivery Systems

Current Medicinal Chemistry, Vol. 23, Iss. 31, 2016-09 ,pp. : 3618-3631

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances on the Role of Neurogenesis in the Adult Brain: Therapeutic Potential in Parkinson's and Alzheimer's Diseases

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 7, 2017-10 ,pp. : 740-748

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Drug Delivery Systems for Releasing Growth Factors to the CNS: Focus on Alzheimer’s and Parkinson’s Diseases

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 7, 2014-06 ,pp. : 557-566

Bentham Science Publishers

Access to resources Recommend Favorite

Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases

Current Drug Metabolism, Vol. 18, Iss. 9, 2017-12 ,pp. : 868-876

Bentham Science Publishers

Access to resources Recommend Favorite

Interleukin-5, Eosinophilic Diseases and Therapeutic Intervention

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 4, 2003-12 ,pp. : 319-328

Bentham Science Publishers

Access to resources Recommend Favorite